The Uromigos Episode 175: Altering the Microbiome in Renal Cancer With CBM588
In this episode, Nazli Dizman and the Uromigos cover an update on the CBM588 probiotic strain and its phase II trial that combines the drug with ipilimumab and nivolumab to treat renal cancer. The data was presented at ASCO 2022.
670 Madison Ave.
Manalapan, NJ 07726
Contributors and Partners
Cancer Nursing Today
Urban Health Today
Blood Cancers Today
© 2022 Mashup Media, LLC. All rights reserved.